EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome

Keith M Gunapala iD, Aseel Gadban, Faiza Noreen iD, Primo Schär, Nissim Benvenisty, Verdon Taylor iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Keith M Gunapala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland. Hauptthemen laut MEDLINE: Fragile X Syndrome, Induced Pluripotent Stem Cells, Organoids, Ascorbic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Botnar, Basel Research Centre for Child Health, Azrieli Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fragile X Syndrome (FX) is the most common form of inherited cognitive impairment and falls under the broader category of Autism Spectrum Disorders (ASD). FX is caused by a CGG trinucleotide repeat expansion in the non-coding region of the X-linked Fragile X Messenger Ribonucleoprotein 1 (FMR1) gene, leading to its hypermethylation and epigenetic silencing. Animal models of FX rely on the deletion of the Fmr1 gene, which fails to replicate the epigenetic silencing mechanism of the FMR1 gene observed in human patients. Human stem cells carrying FX repeat expansions have provided a better understanding of the basis of epigenetic silencing of FMR1. Previous studies have found that 5-Azacytidine (5Azac) can reverse this methylation; however, 5Azac can be toxic, which may limit its therapeutic potential. Here, we show that the dietary factor Ascorbic Acid (AsA) can reduce DNA methylation in the FMR1 locus and lead to an increase in FMR1 gene expression in FX iPSCs and cerebral organoids. In addition, AsA treatment rescued neuronal gene expression and morphological defects observed in FX iPSC-derived cerebral organoids. Hence, we demonstrate that the dietary co-factor AsA can partially revert the molecular and morphological defects seen in human FX models in vitro. Our findings have implications for the development of novel therapies for FX in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fragile X SyndromeInduced Pluripotent Stem CellsOrganoidsAscorbic AcidFragile X Messenger Ribonucleoprotein 1DNA MethylationHumansEpigenesis, GeneticBrain

Stichwörter der Autor:innen

Ascorbic AcidAutism Spectrum Disorders (ASD)FMR1Fragile X Syndromecerebral organoidsgene silencinginduced pluripotent stem cellsmethylationneurodevelopmental disorders

Substanzen

Ascorbic AcidFragile X Messenger Ribonucleoprotein 1FMR1 protein, human

Autor:innen und Institutionen

  • Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • The Azrieli Center for Stem Cells and Genetic Research, Department of Genetics, Institute of Life Sciences, The Hebrew University, Jerusalem 91904, Israel.
  • Swiss Institute of Bioinformatics, 4031 Basel, Switzerland.

ORCID-Profile: Keith M Gunapala, Faiza Noreen, Verdon Taylor

Förderung

  • Fondation Botnar
  • Basel Research Centre for Child Health
  • Azrieli Foundation
  • Israel Science Foundation
  • Rosetrees Trust
  • ISF-Israel Precision Medicine Partnership (IPMP) Program

Zitieren

APA

Gunapala, K. M., Gadban, A., Noreen, F., Schär, P., Benvenisty, N., & Taylor, V. (2024). Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312718

Vancouver

Gunapala KM, Gadban A, Noreen F, Schär P, Benvenisty N, Taylor V. Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312718

BibTeX
@article{Gunapala2024,
  author = {Gunapala, Keith M and Gadban, Aseel and Noreen, Faiza and Schär, Primo and Benvenisty, Nissim and Taylor, Verdon},
  title = {Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312718}
}
Kostenlos starten →